Literature DB >> 16507232

Diabetes and stroke: part two--treating diabetes and stress hyperglycemia in hospitalized stroke patients.

Valentine Burroughs1, Jesse Weinberger.   

Abstract

It is well established that strict glycemic control for the hospitalized stroke patient is associated with improved outcome compared with poor control. This is particularly true for the stroke patients because hyperglycemia can adversely affect ischemic damage. A blood sugar level of less than 110 mg/dL is recommended for critically ill patients and should be achieved by intravenous insulin administration in an intensive care unit setting. Many stroke patients are unable to swallow, and insulin requirement must be readjusted carefully to conform to the nutritional state of the patient. The transition from intravenous insulin to subcutaneous insulin or oral antihyperglycemic agents must be carefully monitored. Careful discharge planning of diabetic care for the stroke patient is necessary to prevent long-term sequelae of inadequate control.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16507232     DOI: 10.1007/s11886-006-0007-0

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  22 in total

Review 1.  Management of diabetes and hyperglycemia in hospitals.

Authors:  Stephen Clement; Susan S Braithwaite; Michelle F Magee; Andrew Ahmann; Elizabeth P Smith; Rebecca G Schafer; Irl B Hirsch; Irl B Hirsh
Journal:  Diabetes Care       Date:  2004-02       Impact factor: 19.112

2.  Mortality in hospitalized patients with hypoglycemia and severe hyperglycemia.

Authors:  A Stagnaro-Green; M K Barton; P L Linekin; E Corkery; K deBeer; S H Roman
Journal:  Mt Sinai J Med       Date:  1995-11

3.  Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas.

Authors:  R I Shorr; W A Ray; J R Daugherty; M R Griffin
Journal:  Arch Intern Med       Date:  1997 Aug 11-25

4.  Standards of medical care in diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2005-01       Impact factor: 19.112

Review 5.  Insulin analogues.

Authors:  Irl B Hirsch
Journal:  N Engl J Med       Date:  2005-01-13       Impact factor: 91.245

6.  Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus; results from the DIGAMI study.

Authors:  B Almbrand; M Johannesson; B Sjöstrand; K Malmberg; L Rydén
Journal:  Eur Heart J       Date:  2000-05       Impact factor: 29.983

7.  Permissive underfeeding of the critically ill patient.

Authors:  Khursheed N Jeejeebhoy
Journal:  Nutr Clin Pract       Date:  2004-10       Impact factor: 3.080

8.  Glucose in parenteral nutrition: a survey of U.S. medical centers.

Authors:  Paul R Schloerb
Journal:  JPEN J Parenter Enteral Nutr       Date:  2004 Nov-Dec       Impact factor: 4.016

Review 9.  Molecular mechanisms by which metabolic control may improve outcomes.

Authors:  Derek Le Roith
Journal:  Endocr Pract       Date:  2004 Mar-Apr       Impact factor: 3.443

Review 10.  Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy.

Authors:  Bruce W Bode; Susan S Braithwaite; R Dennis Steed; Paul C Davidson
Journal:  Endocr Pract       Date:  2004 Mar-Apr       Impact factor: 3.443

View more
  1 in total

1.  Glucose levels and insulin secretion in surgery-induced hyperglycemia in normoglycemic obese patients.

Authors:  Marina Michalaki; Venetsana Kyriazopoulou; Panagiotis Mylonas; Maria-Ioanna Argentou; Yves Debaveye; Fotis Kalfarentzos; Apostolos G Vagenakis
Journal:  Obes Surg       Date:  2008-05-10       Impact factor: 4.129

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.